← Leaderboards
Sadaf Amin
Weill Medical Coll Of Cornell Univ
$570,482
Attributed
$570,482
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $319.6K · FY2023–25$500K$375K$250K$125K$0
'23
'24
'25
Funding mix
By agency
NIH$570,482 · 2
By mechanism
K99$326,462 · 1
R00$244,020 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Samuel F Bakhoum$6,006,178
- Ashley Marie Laughney$5,111,057
- Shelli Farhadian$5,545,336
- Jorge Moscat$21,067,408
- Sudha R Guttikonda$191,748
Others in their field
Other Rising Stars on “Alzheimer&Apos”
- Kjetil Bjornevik · Harvard University D/B/A Harvard School Of Public Health$3,280,861
- Yanling Wang · Rush University Medical Center$2,986,919
- William G Mantyh · University Of Minnesota$2,961,521
- Allison Mercedes Caban-Holt · University Of Miami School Of Medicine$2,611,182
- Brian Stephen Appleby · Cleveland Clinic Lerner Com-Cwru$2,482,260
- Noah Ray Johnson · University Of Colorado Denver$2,282,487
Research focus
Alzheimer&AposMediatorExperimental StudyImmune SignalingLearningMediatingGenesBehavioral AssayHuman ModelImmuneEfficacious TreatmentInterferonsCell PhysiologyCellsInnate Immune SystemElectrophysiology (Science)Crispr ScreenCyclic GmpAmino AcidsGenetic MaterialsBrainHuman Pluripotent Stem CellAmyotrophic Lateral SclerosisMemory Impairment
Grant awards (4)
Investigating the role of cGAS signaling and microglial senscence in tauopathy$244,020
R00 · FY2025 · AG · contact PI
Investigating the role of cGAS signaling and microglial senscence in tauopathy$75,600
K99 · FY2025 · AG · contact PI
Investigating the role of cGAS signaling and microglial senscence in tauopathy$125,431
K99 · FY2024 · AG · contact PI
Investigating the role of cGAS signaling and microglial senscence in tauopathy$125,431
K99 · FY2023 · AG · contact PI